Latest News

2 new influenza strains recommended for next season


 

REPORTING FROM AN FDA ADVISORY COMMITTEE MEETING

The CDC estimate of current vaccine effectiveness (VE) against influenza A (H3N2) viruses is 25%, as of Feb. 3. Effectiveness is even higher for all influenza viruses, with an estimated VE of 36%, indicating that the flu vaccine reduced a person’s risk of having to seek medical care at a doctor’s office for flu illness by 36% ( MMWR. 2018;67:180-5 ).

While the FDA usually follows the recommendations of its panel members, it is not obligated to do so. None of the committee members disclosed relevant financial conflicts of interest.

Pages

Recommended Reading

FDA bans 24 ingredients from OTC health care antiseptic products
MDedge ObGyn
Teens with PID underscreened for HIV, syphilis
MDedge ObGyn
Influenza vaccination of pregnant women needs surveillance
MDedge ObGyn
Zika-linked birth defects climbing in U.S. hot spots
MDedge ObGyn
Trial seeks improved regimens for pregnant women with HIV
MDedge ObGyn
Adacel Tdap effective throughout third trimester vaccination window
MDedge ObGyn
USPSTF: Screen all pregnant women for syphilis
MDedge ObGyn
nPEP for HIV: Updated CDC guidelines available for primary care physicians
MDedge ObGyn
Flu increase may be slowing
MDedge ObGyn
HCV infection tied to premature ovarian senescence and a high miscarriage rate
MDedge ObGyn